HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group.

AuthorsAnnamaria Cseh, Charlotte M Niemeyer, Ayami Yoshimi, Michael Dworzak, Henrik Hasle, Marry M van den Heuvel-Eibrink, Franco Locatelli, Riccardo Masetti, Markus Schmugge, Ute Groß-Wieltsch, Andrea Candás, Andreas E Kulozik, Lale Olcay, Meinolf Suttorp, Ingrid Furlan, Brigitte Strahm, Christian Flotho
JournalBlood (Blood) Vol. 125 Issue 14 Pg. 2311-3 (Apr 02 2015) ISSN: 1528-0020 [Electronic] United States
PMID25838281 (Publication Type: Letter, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Antimetabolites, Antineoplastic
  • Azacitidine
Topics
  • Antimetabolites, Antineoplastic (therapeutic use)
  • Azacitidine (therapeutic use)
  • Child
  • Child, Preschool
  • Cytogenetic Analysis
  • Dose-Response Relationship, Drug
  • Female
  • Follow-Up Studies
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Infant
  • Leukemia, Myelomonocytic, Juvenile (drug therapy, genetics)
  • Male
  • Myelodysplastic Syndromes
  • Prognosis
  • Remission Induction
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: